News

Remarkable Rise in Patient Self-Scheduling Efforts

Remarkable Rise in Patient Self-Scheduling Efforts

Remarkable Rise in Patient Self-Scheduling Efforts

Clearwave Data Shows Significant Improvements in Patient Acquisition and Staff Efficiency

Clearwave, a frontrunner in patient scheduling solutions, has unveiled new client findings that highlight a soaring 87% adoption rate for patient self-scheduling among healthcare practices. This surge in utilization speaks volumes about a changing healthcare landscape, where convenience and efficiency are at the forefront of patient and provider interactions.

Mike Lamb, CEO of Clearwave, expressed his enthusiasm saying, "This significant increase in self-scheduling represents a pivotal change in how patients access care. However, it's essential to recognize that not all scheduling solutions are designed equally. Practices that invest in sophisticated scheduling technologies that align with their unique workflows will emerge as leaders in patient care and operational efficiency. Simply implementing a self-scheduling feature isn't sufficient; it’s the thoughtful integration of such tools that creates a meaningful impact on patient experience and practice outcomes."

Clearwave’s intelligent scheduling capabilities empower patients to take charge of their appointment setting. The solution alleviates administrative burdens, reduces staff hours by as much as 1,500, and cuts acquisition costs while maintaining accuracy. As the cost of hiring medical administrative assistants hovers around $19 per hour nationwide, effective online scheduling tools like Clearwave are proving invaluable for practices looking to enhance efficiency while cutting costs.

Impressive Operational Results Across the Board

Clearwave's client data showcases astonishing operational achievements, making it evident that their scheduling platform is tailored to meet the complexities of various healthcare environments. Statistics reveal that practices using Clearwave often save between 500 to 1,500 full-time employee hours annually. Additionally, reports indicate that these practices experience labor cost savings exceeding $29,000 and a 174% increase in monthly patient visits post-implementation.

Healthcare Access for All Ages

Clearwave’s scheduling platform has demonstrated exceptional adoption rates among different age groups, challenging the common notion that younger patients are the sole benefactors of online scheduling. Lauren Lawson, Director of Marketing at the Center for Sports Medicine & Orthopedics, noted the increasing interest from older demographics who are embracing online scheduling. "This shift indicates a growing trend that older patients also value the flexibility and access provided by self-scheduling tools, allowing practices to meet diverse needs," Lawson said.

 

Success from Real-World Applications

The Thomas Eye Group's integration of Clearwave Scheduling illustrates the real-time benefits that practices can achieve. They reported a 174% increase in monthly patient visits, confirming that online tools have lowered abandonment rates for calls and appointments, thereby expanding their patient base daily. Senior Manager of Patient Experience at the group, Noitavia Fitts, highlighted how crucial it was to configure online workflows to stay competitive and keep the staff’s workload manageable.

Enhanced Accuracy for Better Patient Experiences

Healthcare leaders recognize the vital role of accurate online scheduling in improving operational flow. The Center for Sports Medicine & Orthopedics, for example, successfully books nearly 700 appointments each month, with around 23% being made by new patients. Connie Roberts, the Chief Operating Officer, remarked on the transformation saying, "We’ve significantly reduced downtime once spent rescheduling and are now focused on refining our service offerings." This improvement exemplifies how a well-configured scheduling solution enhances not only the patient experience but also operational workflows.

The Orthopaedic Group highlights the importance of accurate online scheduling. With 26 providers utilizing Clearwave, their Director of Operations, Jennifer Lott, explained, "We’re equipped to accommodate over 500 patients daily, ensuring accuracy that previous methods didn’t guarantee. This efficiency has revolutionized our day-to-day operations for the better."

Adopting Clearwave in Today's Healthcare Marketplace

Dustin Bostwick, Sr. Marketing & Communications Manager at Marietta Eye Clinic, shared his perspective on the current scheduling market, emphasizing Clearwave's unique level of customization that sets it apart from competitors. His team's early implementation experiences have shown how adaptability in scheduling can lead to long-term benefits for practices and patients alike.

The competitive landscape in healthcare today necessitates solutions like Clearwave's patient-led self-service platform, which can streamline operations and prioritize patient engagement. For healthcare practices seeking to elevate their operations and improve patient experiences, Clearwave stands ready to help reshape their scheduling methodologies, ensuring that they remain responsive to evolving patient demands.

About Clearwave

Clearwave is synonymous with optimizing operations for specialized healthcare practices while enhancing patient experiences. Their Patient-Led Self-Service Platform integrates various services, including scheduling, registration, clinical intake, and payment processing, to boost productivity while minimizing staffing challenges. Clearwave commits to innovation and partner success within the dynamic landscape of healthcare, encouraging practices to prioritize patient satisfaction and operational integrity. Explore more on optimizing patient experiences with Clearwave and refine your practice's capabilities.

Frequently Asked Questions

What is the adoption rate for patient self-scheduling at Clearwave?

The adoption rate for patient self-scheduling solutions at Clearwave has reached an impressive 87% across various healthcare practices.

How does Clearwave improve staff efficiency?

Clearwave reduces staff burdens by automating scheduling, leading to significant time savings and allowing healthcare providers to focus on patient care.

What cost savings have practices experienced using Clearwave?

Practices utilizing Clearwave have reported labor cost savings of over $29,000 annually due to enhanced scheduling efficiencies.

Is Clearwave suitable for all patient demographics?

Yes, Clearwave has shown notable adoption rates across all age groups, demonstrating its accessibility and appeal to various patient demographics.

How does Clearwave contribute to patient satisfaction?

By providing convenient self-scheduling options, Clearwave enhances patient experiences, allowing them to book appointments at their convenience.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading